You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
POSTER PRESENTATIONS<br />
P 242<br />
Poster: Devices & Intervention<br />
SINGLE USE NEGATIVE PRESSURE WOUND THERAPY (SU-NPWT) FOR THE<br />
MANAGEMENT OF SPLIT THICKNESS SKIN GRAFT (STSG) DONOR SITES<br />
John Lantis 1 , Jamie Schwartz 1 , Ema Avdagic 1 , Cynthia Gendics 1<br />
1 St Luke’s-Roosevelt Hospital; Columbia University (New York, United States).<br />
Aim: STSG donor sites usually do quite well with near complete epithelialization at 7-14<br />
days. Donor site management entails maintaining a moist wound healing environment.<br />
Polyurethane films are better than mesh gauze but do not handle exudate well and in<br />
donor sites there is level I evidence that moist wound healing products are superior to<br />
dry products. We undertook a study of standard of care polyurethane dressing (PUD) to<br />
a single use, disposable NPWT system (SU-NPWT).<br />
Methods: 10 patients acted as their own control with 50% of the donor site being<br />
covered with a PUD and the other half being covered with the silicone interface of the<br />
SU-NPWT. The wound closure rate, pain at removal, amount of granulation vs<br />
epithelialization and periwound skin integrity was measures at post op day 4,7,14 and<br />
28.<br />
Results: The SUD- NPWT was associated with similar pain to the PUD. However,<br />
exudate management was superior with the SU-NPWT. In general the SU-NPWT only<br />
needed to be changed at the designated interval while the PUD required much more<br />
frequent re-enforcement.<br />
Conclusion: Consensus documents have previously supported some form of positive<br />
pressure to the donor wound for 48 hours, a dressing that should remain intact as long<br />
as possible, and a dressing that controls wound exudate. The SU –NPWT fit all of these<br />
criteria; providing positive pressure by way of a very tight interface with a space<br />
occupying dressing, controlling for exudate and being able to stay in place for 7 days.<br />
POSTER: DEVICES & INTERVENTION<br />
P 243<br />
Poster: Devices & Intervention<br />
SINGLE USE NEGATIVE PRESSURE WOUND THERAPY (SU-NPWT) FOR THE<br />
MANAGEMENT OF VASCULAR SURGERY INCISIONS<br />
John Lantis 1 , Joseph Wuamett 1 , Jamie Schwartz 1 , Ema Avdagic 1 , Cynthia Gendics 1<br />
1 St Luke’s-Roosevelt Hospital; Columbia University (New York, United States).<br />
Aim: The ideal surgical dressing has been described as providing a moist wound<br />
environment to promote optimal healing, while allowing high water vapor permeability<br />
and absorbency, while providing protection from external trauma and contaminates.<br />
NPWT has been advanced as a way of addressing the above ideal surgical dressing<br />
needs.<br />
Methods: Using a high risk population as defined by SENIC and others we undertook a<br />
prospective study of the use of SU-NPWT on leg incisions in patients undergoing<br />
vascular surgical procedures. Wound complications rates were assessed at 4, 14, 28<br />
and 90 days. The control group was a historic cohort of similar patients. SU-NPWT was<br />
terminated after 14 days in all patients<br />
Results: Incisions and demographic s was representative of this population. The<br />
average length of the incision was 19.5 cm. Distal targets were above knee in 20%,<br />
below knee in 60%, 10% ileofemoral and 10% popliteal aneurysm repair. In 30% the<br />
dressing was saturated prior to the first change, there were no infections at day 7, while<br />
20% appeared inflamed. At the time of SU-NPWT termination 30% of the wounds were<br />
closed, 60% had the dressing changed to non-stick gauze and a polyurethane<br />
membrane. In 60% of wounds the dressing exceeded expectations, in 100% it was<br />
graded as better than standard of care.<br />
Discussion: The SUD-NPWT appeared to meet many of the requirements outlined as<br />
components of the ideal dressing for high risk leg incisions. It appears to have the best<br />
outcomes if used for 14 days.<br />
150